The chief executive of Moderna has predicted that existing vaccines will be much less effective at tackling Omicron than earlier strains of Covid-19 and warned it would take months before pharmaceutical companies can manufacture new variant-specific jabs at scale.
莫德納(Moderna)執行長預測，現有疫苗在應對Omicron方面的效果將遠不如應對先前的Covid-19毒株。他警告稱，製藥公司需要幾個月時間才能大規模生產新的變種疫苗。
您已閱讀6%（354字），剩餘94%（6018字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。